The goal sought by our transplant group was to try to create selection criteria that could make transplantation for amyloidosis as safe as it is for multiple myeloma. We set our criteria at an all ...

which recently have shown to have antitumor activity in multiple myeloma, may also be of therapeutic value in treating primary amyloidosis (Gertz, 2002; Khan & Falk, 2001). A more aggressive ...

It may also occur in association with multiple myeloma (Smith, 2003). Secondary amyloidosis occurs in association with chronic inflammatory or infectious diseases. Most patients who are diagnosed ...

Advanced treatment at Loyola University Medical Center is offering remission from a rare blood cancer. Thanks to Loyola’s ...

This change happens with very few people. Most people with MGUS never get a more serious condition. MGUS can turn into multiple myeloma. It also can turn into another blood disease, either: ...

A multiple myeloma diagnosis is a life event that can be overwhelming. Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no ...

Multiple myeloma is a rare blood cancer that develops in the plasma cells, which are white blood cells that help you fight infection by making antibodies. Multiple myeloma starts in the plasma ...

Multiple myeloma (also referred to as myeloma) is a type of rare, incurable cancer of the blood—also known as hematologic cancer. It affects cells called plasma cells, which are types of white ...

Dr. Rahul Banerjee is a physician-researcher who specializes in multiple myeloma, a blood cancer caused by plasma cells that can cause bone and kidney damage. Dr. Banerjee also treats patients with AL ...